Trial · NCT06199843
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of recurrence of SBP within 6 months | 6 months | |
| Secondary | Incidence of recurrence of SBP within12 months | 12 months | |
| Secondary | Incidence of other site infections within 6 months | 6 months | |
| Secondary | Incidence of other site infections within 12 months | 12 months | |
| Secondary | to look for resistance pattern of infection in both norfloxacin and rifampicin group, type of resistant bacteria (MDR/XDR), and response of both groups to rifampicin and norfloxacin in secondary prophylaxis of SBP | 12 months | |
| Secondary | Incidence of other complications (HE, variceal bleed, Refractory ascites, AKI) within 6 months | 6 months | |
| Secondary | Incidence of other complications (HE, variceal bleed, Refractory ascites, AKI) within 12 months) | 12 months | |
| Secondary | Transplant free survival by 6 months | 6 months | |
| Secondary | Transplant free survival by 12 months | 12 months | |
| Secondary | Change in Child-Turcotte-Pugh (CTP) by 6 months | 6 months | |
| Secondary | Change in Model for End-Stage Liver Disease (MELD) scores by 6 months | 6 months | |
| Secondary | Change in Model for End-Stage Liver Disease Sodium (MELD Na) scores by 6 months | 6 months | |
| Secondary | Change in Child-Turcotte-Pugh (CTP) scores by 12 months | 12 months | |
| Secondary | Change in Model for End-Stage Liver Disease (MELD) scores by 12 months | 12 months | |
| Secondary | Change in MELD-Na scores by 12 months | 12 months | |
| Secondary | Side effects in both groups | 12 months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06199843/registered